Federated Hermes
CATX icon

Federated Hermes’s Perspective Therapeutics CATX Stock Holding History

Federated Hermes’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$926K Buy
222,142
+8,383
+4% +$35.4K ﹤0.01% 1136
2025
Q4 		$588K Buy
213,759
+15,568
+8% +$44.4K ﹤0.01% 1264
2025
Q3 		$680K Buy
198,191
+3,111
+2% +$11.3K ﹤0.01% 1261
2025
Q2 		$671K Buy
195,080
+60,019
+44% +$158K ﹤0.01% 1253
2025
Q1 		$288K Buy
+135,061
New +$405K ﹤0.01% 1436

Other funds holding CATX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federated Hermes's CATX Position: Q1 2026 in Review

Federated Hermes increased its Perspective Therapeutics (CATX) stake by 3.9% in Q1 2026, buying an estimated $35.4K and bringing the position to 222,142 shares worth $926K. The position accounts for ﹤0.01% of the portfolio, ranked #1136.

Federated Hermes first reported a position in CATX in Q1 2025 and has held it in 5 quarters since. 138 funds tracked by Wall St. Rank hold CATX as of Q1 2026.

  • Federated Hermes held 222,142 shares of Perspective Therapeutics worth $926K as of Q1 2026.
  • Federated Hermes bought 8,383 Perspective Therapeutics shares in Q1 2026, an estimated $35.4K.
  • Perspective Therapeutics made up ﹤0.01% of Federated Hermes's portfolio in Q1 2026, its #1136 holding.
  • Federated Hermes first reported a position in Perspective Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • 138 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.